Tag: pAVF
Venova Medical announces US$30 million Series B financing and appointment of...
Venova Medical has announced the initial closing of a US$30M Series B funding round. Catalyst Health Ventures and a leading medical device company co-led...
PAVF less likely to result in steal syndrome and wound infection...
Percutaneous endovascular arteriovenous fistula (pAVF) procedures carry a lower risk of steal syndrome and wound infection than surgical arteriovenous fistula creation (sAVF), a new...
Study indicates lower wound infection and surgical reintervention rates in pAVF...
A single-centre, retrospective, comparative study, which was presented at the July 2021 Journal of Vascular Surgery (JVS) Journal Club (14 July, online), has found...
Benefits of percutaneous fistula creation further bolstered by five-year Ellipsys data
The Ellipsys vascular access system (Avenu Medical/Medtronic) can be used to easily and safely create durable percutaneous arteriovenous fistulas (pAVFs) for haemodialysis—with new, long-term...
Cannulation difficulties among biggest hurdles for device-created fistulas
Difficulties in cannulation are currently as pressing as any other challenge facing patients who undergo device-enabled arteriovenous fistula (AVF) creation for dialysis. This was...